메뉴 건너뛰기




Volumn 144, Issue 4, 2013, Pages

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997

Author keywords

cART; Disease Progression; Epidemiology; Immune Deficiency

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 84875275752     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.12.026     Document Type: Article
Times cited : (87)

References (43)
  • 1
    • 33745078633 scopus 로고    scopus 로고
    • Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
    • CASCADE Collaboration
    • C. Smit, R. Geskus, S. Walker CASCADE Collaboration Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion AIDS 20 2006 741 749
    • (2006) AIDS , vol.20 , pp. 741-749
    • Smit, C.1    Geskus, R.2    Walker, S.3
  • 2
    • 33748116898 scopus 로고    scopus 로고
    • Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study
    • F.J. Palella, R.K. Baker, A.C. Moorman Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 2006 27 34
    • (2006) J Acquir Immune Defic Syndr , vol.43 , pp. 27-34
    • Palella, F.J.1    Baker, R.K.2    Moorman, A.C.3
  • 3
    • 65449136656 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C: An update
    • M.G. Ghany, D.B. Strader, D.L. Thomas Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
    • (2009) Hepatology , vol.49 , pp. 1335-1374
    • Ghany, M.G.1    Strader, D.B.2    Thomas, D.L.3
  • 4
    • 53549115066 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis
    • H.H. Thein, Q. Yi, G.J. Dore Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis AIDS 22 2008 1979 1991
    • (2008) AIDS , vol.22 , pp. 1979-1991
    • Thein, H.H.1    Yi, Q.2    Dore, G.J.3
  • 5
    • 72849116931 scopus 로고    scopus 로고
    • Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression
    • T.Y. Chen, E.L. Ding, G.R. Seage Iii Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression Clin Infect Dis 49 2009 1605 1615
    • (2009) Clin Infect Dis , vol.49 , pp. 1605-1615
    • Chen, T.Y.1    Ding, E.L.2    Seage Iii, G.R.3
  • 6
    • 24644443695 scopus 로고    scopus 로고
    • Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
    • J.K. Rockstroh, A. Mocroft, V. Soriano Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy J Infect Dis 192 2005 992 1002
    • (2005) J Infect Dis , vol.192 , pp. 992-1002
    • Rockstroh, J.K.1    Mocroft, A.2    Soriano, V.3
  • 7
    • 84869495977 scopus 로고    scopus 로고
    • Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy
    • J. Berenguer, B. Alejos, V. Hernando Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy AIDS 26 2012 2241 2246
    • (2012) AIDS , vol.26 , pp. 2241-2246
    • Berenguer, J.1    Alejos, B.2    Hernando, V.3
  • 8
    • 10244242497 scopus 로고    scopus 로고
    • The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy
    • M. Dorrucci, C. Valdarchi, B. Suligoi The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy AIDS 18 2004 2313 2318
    • (2004) AIDS , vol.18 , pp. 2313-2318
    • Dorrucci, M.1    Valdarchi, C.2    Suligoi, B.3
  • 9
    • 8444248309 scopus 로고    scopus 로고
    • Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database
    • N. Voirin, C. Trépo, P. Miailhes Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database J Viral Hepat 11 2004 559 562
    • (2004) J Viral Hepat , vol.11 , pp. 559-562
    • Voirin, N.1    Trépo, C.2    Miailhes, P.3
  • 10
    • 0038163753 scopus 로고    scopus 로고
    • The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy
    • M.B. Klein, R.G. Lalonde, S. Suissa The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 2003 365 372
    • (2003) J Acquir Immune Defic Syndr , vol.33 , pp. 365-372
    • Klein, M.B.1    Lalonde, R.G.2    Suissa, S.3
  • 11
    • 13244267370 scopus 로고    scopus 로고
    • Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection
    • C.C. Hung, M.Y. Chen, S.M. Hsieh Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection Int J STD AIDS 16 2005 42 48
    • (2005) Int J STD AIDS , vol.16 , pp. 42-48
    • Hung, C.C.1    Chen, M.Y.2    Hsieh, S.M.3
  • 12
    • 13544259969 scopus 로고    scopus 로고
    • Survival in hepatitis C and HIV co-infection: A cohort study of hospitalized veterans
    • H.B. El-Serag, T.P. Giordano, J. Kramer Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans Clin Gastroenterol Hepatol 3 2005 175 183
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 175-183
    • El-Serag, H.B.1    Giordano, T.P.2    Kramer, J.3
  • 13
    • 0036453090 scopus 로고    scopus 로고
    • Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy
    • J. Macías, I. Melguizo, F.J. Fernández-Rivera Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy Eur J Clin Microbiol Infect Dis 21 2002 775 781
    • (2002) Eur J Clin Microbiol Infect Dis , vol.21 , pp. 775-781
    • Macías, J.1    Melguizo, I.2    Fernández-Rivera, F.J.3
  • 14
    • 7944226613 scopus 로고    scopus 로고
    • An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients
    • C. Lewden, H. Jacqmin-Gadda, J.L. Vilde An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients HIV Clin Trials 5 2004 224 231
    • (2004) HIV Clin Trials , vol.5 , pp. 224-231
    • Lewden, C.1    Jacqmin-Gadda, H.2    Vilde, J.L.3
  • 15
    • 0034305946 scopus 로고    scopus 로고
    • Changes in the uptake of antiviral therapy and survival in people with known duration of HIV infection in Europe: Results from CASCADE
    • CASCADE Collaboration
    • CASCADE Collaboration Changes in the uptake of antiviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE HIV Med 1 2000 224 231
    • (2000) HIV Med , vol.1 , pp. 224-231
  • 16
    • 80051546683 scopus 로고    scopus 로고
    • The Coding Causes of Death in HIV (CoDe) Project: Initial results and evaluation of methodology
    • J.D. Kowalska, N. Friis-Moller, O. Kirk The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology Epidemiology 22 2011 516 523
    • (2011) Epidemiology , vol.22 , pp. 516-523
    • Kowalska, J.D.1    Friis-Moller, N.2    Kirk, O.3
  • 17
    • 85027944119 scopus 로고    scopus 로고
    • The hepatitis C epidemic among HIV-positive MSM: Incidence estimates from 1990 to 2007
    • J.J. van der Helm, M. Prins, J. del Amo The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007 AIDS 25 2011 1083 1091
    • (2011) AIDS , vol.25 , pp. 1083-1091
    • Van Der Helm, J.J.1    Prins, M.2    Del Amo, J.3
  • 18
    • 69949108828 scopus 로고    scopus 로고
    • Imputing missing covariate values for the Cox model
    • I.R. White, P. Royston Imputing missing covariate values for the Cox model Stat Med 28 2009 1982 1998
    • (2009) Stat Med , vol.28 , pp. 1982-1998
    • White, I.R.1    Royston, P.2
  • 22
    • 34248397713 scopus 로고    scopus 로고
    • Tutorial in biostatistics: Competing risks and multi-state models
    • 2389-2340
    • H. Putter, M. Fiocco, R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389-2340
    • (2007) Stat Med , vol.26
    • Putter, H.1    Fiocco, M.2    Geskus, R.B.3
  • 23
    • 78650235570 scopus 로고    scopus 로고
    • Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring
    • R.B. Geskus Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring Biometrics 67 2011 39 49
    • (2011) Biometrics , vol.67 , pp. 39-49
    • Geskus, R.B.1
  • 24
    • 70149113077 scopus 로고    scopus 로고
    • R development Core Team R Foundation for Statistical Computing Vienna, Austria Accessed December 17, 2012
    • R development Core Team R: a language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna, Austria http://www.R-project.org Accessed December 17, 2012
    • (2009) R: A Language and Environment for Statistical Computing
  • 25
    • 77955553749 scopus 로고    scopus 로고
    • The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models
    • L.C. de Wreede, M. Fiocco, H. Putter The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models Comput Methods Programs Biomed 99 2010 261 274
    • (2010) Comput Methods Programs Biomed , vol.99 , pp. 261-274
    • De Wreede, L.C.1    Fiocco, M.2    Putter, H.3
  • 26
    • 0034715950 scopus 로고    scopus 로고
    • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study
    • G. Greub, B. Ledergerber, M. Battegay Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 2000 1800 1805
    • (2000) Lancet , vol.356 , pp. 1800-1805
    • Greub, G.1    Ledergerber, B.2    Battegay, M.3
  • 27
    • 0037055011 scopus 로고    scopus 로고
    • Hepatitis C and progression of HIV disease
    • M.S. Sulkowski, R.D. Moore, S.H. Mehta Hepatitis C and progression of HIV disease JAMA 288 2002 199 206
    • (2002) JAMA , vol.288 , pp. 199-206
    • Sulkowski, M.S.1    Moore, R.D.2    Mehta, S.H.3
  • 28
    • 79952705520 scopus 로고    scopus 로고
    • HIV/HCV co-infection: Pathogenesis, clinical complications, treatment, and new therapeutic technologies
    • E.A. Operskalski, A. Kovacs HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies Curr HIV/AIDS Rep 8 2011 12 22
    • (2011) Curr HIV/AIDS Rep , vol.8 , pp. 12-22
    • Operskalski, E.A.1    Kovacs, A.2
  • 29
    • 80054948562 scopus 로고    scopus 로고
    • HIV and hepatitis C co-infection: The role of HAART in HIV/hepatitis C virus management
    • M. Jones, M. Nunez HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management Curr Opin HIV AIDS 6 2011 546 552
    • (2011) Curr Opin HIV AIDS , vol.6 , pp. 546-552
    • Jones, M.1    Nunez, M.2
  • 30
    • 2942567897 scopus 로고    scopus 로고
    • Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
    • W.P. Law, C.J. Duncombe, A. Mahanontharit Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort AIDS 18 2004 1169 1177
    • (2004) AIDS , vol.18 , pp. 1169-1177
    • Law, W.P.1    Duncombe, C.J.2    Mahanontharit, A.3
  • 31
    • 84862572786 scopus 로고    scopus 로고
    • Impact of hepatitis C co-infection on response to antiretroviral treatment
    • F. Pulido, A. Hill, Y. van Delft Impact of hepatitis C co-infection on response to antiretroviral treatment AIDS Rev 14 2012 124 131
    • (2012) AIDS Rev , vol.14 , pp. 124-131
    • Pulido, F.1    Hill, A.2    Van Delft, Y.3
  • 32
    • 80052959049 scopus 로고    scopus 로고
    • Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting
    • T. Reiberger, M. Obermeier, B.A. Payer Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting Antivir Ther 16 2011 815 824
    • (2011) Antivir Ther , vol.16 , pp. 815-824
    • Reiberger, T.1    Obermeier, M.2    Payer, B.A.3
  • 33
    • 67651083226 scopus 로고    scopus 로고
    • Hepatitis C treatment for injection drug users: A review of the available evidence
    • M. Hellard, R. Sacks-Davis, J. Gold Hepatitis C treatment for injection drug users: a review of the available evidence Clin Infect Dis 49 2009 561 573
    • (2009) Clin Infect Dis , vol.49 , pp. 561-573
    • Hellard, M.1    Sacks-Davis, R.2    Gold, J.3
  • 34
    • 34548709023 scopus 로고    scopus 로고
    • Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy
    • J.A. Pineda, J.A. Garcia-Garcia, M. Aguilar-Guisado Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy Hepatology 46 2007 622 630
    • (2007) Hepatology , vol.46 , pp. 622-630
    • Pineda, J.A.1    Garcia-Garcia, J.A.2    Aguilar-Guisado, M.3
  • 35
    • 12244293401 scopus 로고    scopus 로고
    • Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients
    • C. Tural, D. Fuster, J. Tor Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients J Viral Hepat 10 2003 118 125
    • (2003) J Viral Hepat , vol.10 , pp. 118-125
    • Tural, C.1    Fuster, D.2    Tor, J.3
  • 36
    • 0344120830 scopus 로고    scopus 로고
    • Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
    • N. Qurishi, C. Kreuzberg, G. Luchters Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
    • (2003) Lancet , vol.362 , pp. 1708-1713
    • Qurishi, N.1    Kreuzberg, C.2    Luchters, G.3
  • 37
    • 79960453276 scopus 로고    scopus 로고
    • Clinical Practice Guidelines: Management of hepatitis C virus infection
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
    • (2011) J Hepatol , vol.55 , pp. 245-264
  • 38
    • 79959360426 scopus 로고    scopus 로고
    • Influence of antiretroviral therapy on liver disease
    • H. Kovari, R. Weber Influence of antiretroviral therapy on liver disease Curr Opin HIV AIDS 6 2011 272 277
    • (2011) Curr Opin HIV AIDS , vol.6 , pp. 272-277
    • Kovari, H.1    Weber, R.2
  • 39
    • 80855137985 scopus 로고    scopus 로고
    • Challenges and opportunities for hepatitis C drug development in HIV-HCV coinfected patients
    • V. Soriano, K.E. Sherman, J. Rockstroh Challenges and opportunities for hepatitis C drug development in HIV-HCV coinfected patients AIDS 25 2011 2197 2208
    • (2011) AIDS , vol.25 , pp. 2197-2208
    • Soriano, V.1    Sherman, K.E.2    Rockstroh, J.3
  • 40
    • 80054963278 scopus 로고    scopus 로고
    • HIV and hepatitis C co-infection: Acute HCV therapy
    • C. Boesecke, M. Vogel HIV and hepatitis C co-infection: acute HCV therapy Curr Opin HIV AIDS 6 2011 459 464
    • (2011) Curr Opin HIV AIDS , vol.6 , pp. 459-464
    • Boesecke, C.1    Vogel, M.2
  • 41
    • 0037079352 scopus 로고    scopus 로고
    • HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
    • C.L. Thio, E.C. Seaberg, R. Skolasky HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet 360 2002 1921 1926
    • (2002) Lancet , vol.360 , pp. 1921-1926
    • Thio, C.L.1    Seaberg, E.C.2    Skolasky, R.3
  • 42
    • 78349262304 scopus 로고    scopus 로고
    • CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era
    • S. Lodi, A. Phillips, G. Touloumi CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era AIDS 24 2010 2697 2704
    • (2010) AIDS , vol.24 , pp. 2697-2704
    • Lodi, S.1    Phillips, A.2    Touloumi, G.3
  • 43
    • 50649116552 scopus 로고    scopus 로고
    • Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women
    • I. Jarrin, R. Geskus, K. Bhaskaran Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women Am J Epidemiol 168 2008 532 540
    • (2008) Am J Epidemiol , vol.168 , pp. 532-540
    • Jarrin, I.1    Geskus, R.2    Bhaskaran, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.